Sodium-glucose cotransporter 2 inhibitors: An additional management option for patients with atrial fibrillation?

被引：1
|
作者：
Proietti, Riccardo [1 ]
Lip, Gregory Y. H.
机构：
[1] Univ Liverpool, Liverpool Ctr Cardiovasc Sci, Liverpool L69 7TX, Merseyside, England
来源：
DIABETES OBESITY & METABOLISM | 2022年 / 24卷 / 10期
关键词：
antidiabetic drug; canagliflozin; cardiovascular disease; clinical trial; TYPE-2; DIABETES-MELLITUS; SERUM MAGNESIUM; EMPAGLIFLOZIN; INSIGHTS; RISK;
D O I：
10.1111/dom.14818
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1897 / 1900
页数：4
相关论文
共 50 条
  • [1] Atrial fibrillation: Epigenetic aspects and role of sodium-glucose cotransporter 2 inhibitors
    Donniacuo, M.
    De Angelis, A.
    Telesca, M.
    Bellocchio, G.
    Riemma, M. A.
    Paolisso, P.
    Cianflone, E.
    Torella, D.
    Castaldo, G.
    Capuano, A.
    Urbanek, K.
    Berrino, L.
    Rossi, F.
    Cappetta, D.
    [J]. PHARMACOLOGICAL RESEARCH, 2023, 188
  • [2] Sodium-Glucose Cotransporter 2 Inhibitors: The New Option for Diabetes Mellitus Management
    Powell, Jason
    Miller, Shannon A.
    Taylor, James R.
    [J]. SOUTHERN MEDICAL JOURNAL, 2015, 108 (02) : 82 - 90
  • [3] Sodium-glucose cotransporter-2 inhibitors protect against atrial fibrillation in patients with heart failure
    Zhou, Lili
    Yang, Yuanyuan
    Han, Weixing
    [J]. ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (10) : 10887 - 10895
  • [4] Sodium-glucose cotransporter-2 inhibitors had a significant association with less atrial fibrillation
    Xiao, Yu
    Liu, Chao
    [J]. EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 31 (07) : e53 - e54
  • [5] Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors on Outcomes After Catheter Ablation for Atrial Fibrillation
    Kishima, Hideyuki
    Mine, Takanao
    Fukuhara, Eiji
    Kitagaki, Ryo
    Asakura, Masanori
    Ishihara, Masaharu
    [J]. JACC-CLINICAL ELECTROPHYSIOLOGY, 2022, 8 (11) : 1393 - 1404
  • [6] Sodium-Glucose Cotransporter 2 Inhibitors
    Erol, Cetin
    [J]. ANATOLIAN JOURNAL OF CARDIOLOGY, 2024, 28 (05): : 216 - 216
  • [7] Sodium-glucose cotransporter 2 inhibitors for the management of heart failure
    Nouel, Ana
    Winter, Jose Luis
    Sepulveda, Luis
    [J]. REVISTA MEDICA DE CHILE, 2022, 150 (12) : 1647 - 1654
  • [8] IMPACT OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS ON RECURRENCE OF ATRIAL FIBRILLATION AFTER CATHETER ABLATION
    Abu-Qaoud, Moh'D Rasheed
    Kumar, Ashish
    Tarun, Tushar
    Ahmad, Javaria
    Kulbak, Guy
    Januzzi, James L., Jr.
    Neilan, Tomas G.
    Baron, Suzanne
    Martin, David T.
    Nohria, Anju
    Reynolds, Matthew R.
    Kosiborod, Mikhail
    Dani, Sourbha S.
    Ganatra, Sarju
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 37 - 37
  • [9] Efficacy of sodium-glucose cotransporter 2 inhibitors in preventing atrial fibrillation recurrence after catheter ablation
    Stachteas, Panagiotis
    Karakasis, Paschalis
    Karagiannidis, Efstratios
    Patoulias, Dimitrios
    Athanasiadou, Polyxeni
    Nasoufidou, Athina
    Papadopoulos, Christodoulos
    Kassimis, George
    Fragakis, Nikolaos
    [J]. HELLENIC JOURNAL OF CARDIOLOGY, 2024, 79 : 86 - 87
  • [10] Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in patients with atrial fibrillation and type 2 diabetes mellitus
    Oh, Y. S.
    Choi, Y.
    Kim, S. H.
    Kim, S. H.
    Park, S. Y.
    Kim, H. J.
    [J]. EUROPEAN HEART JOURNAL, 2023, 44
12345